{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:43:40Z","timestamp":1786985020257,"version":"build-2736575974"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.bbmt.2019.10.030","type":"journal-article","created":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T00:55:43Z","timestamp":1572742543000},"page":"e38-e50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Revisiting Role of Vaccinations in Donors, Transplant Recipients, Immunocompromised Hosts, Travelers, and Household Contacts of Stem Cell Transplant Recipients"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0502-0233","authenticated-orcid":false,"given":"Aneela","family":"Majeed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoey","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Brucks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Hinchman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arafat Ali","family":"Farooqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Junaid","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavin","family":"Tamizhmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irbaz bin","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azka","family":"Latif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raheel","family":"Iftikhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif","family":"Mossad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6914-7439","authenticated-orcid":false,"given":"Faiz","family":"Anwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2019.10.030_bib0001","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1182\/blood.V69.2.369.369","article-title":"The kinetics of immune reconstitution after human marrow transplantation","volume":"69","author":"Lum","year":"1987","journal-title":"Blood"},{"issue":"Suppl 5","key":"10.1016\/j.bbmt.2019.10.030_bib0002","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1398-2265.2004.00183.x","article-title":"Recent advances in the prevention of CMV infection and disease after hematopoietic stem cell transplantation","volume":"8","author":"Boeckh","year":"2004","journal-title":"Pediatric Transplant"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0003","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0004","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/sj.bmt.1705159","article-title":"The benefit of influenza vaccination after bone marrow transplantation","volume":"36","author":"Machado","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0005","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1442-200X.1996.tb03472.x","article-title":"Clinical features of measles in immunocompromised children","volume":"38","author":"Nakano","year":"1996","journal-title":"Acta Paediatr Jpn"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0006","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0007","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/bmt.2015.47","article-title":"Evaluation of pretransplant influenza vaccination in hematopoietic SCT: a randomized prospective study","volume":"50","author":"Ambati","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0008","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/bmt.2015.49","article-title":"Pretransplant vaccinations in allogeneic stem cell transplantation donors and recipients: an often-missed opportunity for immunoprotection?","volume":"50","author":"Harris","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0009","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/sj.bmt.1704336","article-title":"Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation","volume":"33","author":"Storek","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.bmt.1705562","article-title":"A randomized study on donor immunization with tetanus-diphtheria, Haemophilus influenzae type b and inactivated poliovirus vaccines to improve the recipient responses to the same vaccines after allogeneic bone marrow transplantation","volume":"39","author":"Parkkali","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0011","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/hep.1840180204","article-title":"Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation","volume":"18","author":"Ilan","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0012","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(86)92315-9","article-title":"Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow","volume":"1","author":"Wimperis","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0013","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa013441","article-title":"Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants","volume":"347","author":"Hata","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0014","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/infdis\/jit344","article-title":"Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults","volume":"208","author":"Mullane","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0015","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0016","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/S0140-6736(18)30631-7","article-title":"Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Winston","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0017","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/infdis\/150.3.358","article-title":"Transfer and persistence of viral antibody-producing cells in bone marrow transplantation","volume":"150","author":"Wahren","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0018","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1086\/511641","article-title":"Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation","volume":"44","author":"Patel","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0019","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/cid\/civ287","article-title":"Immunogenicity, safety, and tolerability of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in recipients of allogeneic hematopoietic stem cell transplant aged >\/=2 years: an open-label study","volume":"61","author":"Cordonnier","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0020","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/infdis\/166.5.1021","article-title":"Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients","volume":"166","author":"Barra","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0021","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/1097-0142(19860901)58:5<1047::AID-CNCR2820580512>3.0.CO;2-Y","article-title":"Pulmonary complications occurring after allogeneic bone marrow transplantation. A study of 130 consecutive transplanted patients","volume":"58","author":"Cordonnier","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0022","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/sj.bmt.1701424","article-title":"Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation","volume":"22","author":"Vance","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0023","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1182\/blood-2014-04-573048","article-title":"A phase 1\/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients","volume":"124","author":"Stadtmauer","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0024","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/jama.2019.9053","article-title":"Effect of recombinant zoster vaccine on incidence of herpes zoster after autologous stem cell transplantation: a randomized clinical trial","volume":"322","author":"Bastidas","year":"2019","journal-title":"Jama"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0025","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bbmt.2015.12.025","article-title":"Safety of live attenuated high-titer varicella-zoster virus vaccine in pediatric allogeneic hematopoietic stem cell transplantation recipients","volume":"22","author":"Aoki","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0026","first-page":"1821","article-title":"Practices on behalf of the Advisory Committee on Immunization (obotACoI) Practices by the Advisory Committee on Immunization Practices (ACIP). Recommended adult immunization schedule, United States, 2019","volume":"170","author":"Kim","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0027","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/sj.bmt.1700768","article-title":"A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT","volume":"19","author":"Parkkali","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0028","unstructured":"Flowers Mary ED, McDonald G, Carpenter P. Long-term follow-up after hematopoietic stem cell transplant: general guidelines for referring physicians. Available at: https:\/\/www.fredhutch.org\/content\/dam\/public\/Treatment-Suport\/Long-Term-Follow-Up\/LTFU_HSCT_guidelines_physicians.pdf. Accessed 28 April 2019"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0029","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bbmt.2011.07.027","article-title":"Safety and immunogenicity of the tetravalent protein-conjugated meningococcal vaccine (MCV4) in recipients of related and unrelated allogeneic hematopoietic stem cell transplantation","volume":"18","author":"Mahler","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0030","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.bbmt.2015.12.003","article-title":"Randomized double-blind study of the safety and immunogenicity of standard-dose trivalent inactivated influenza vaccine versus high-dose trivalent inactivated influenza vaccine in adult hematopoietic stem cell transplantation patients","volume":"22","author":"Halasa","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0031","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.vaccine.2013.11.073","article-title":"Comparable humoral response after two doses of adjuvanted influenza A\/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients","volume":"32","author":"Dhedin","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0032","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbmt.2012.08.015","article-title":"A randomized trial of one versus two doses of influenza vaccine after allogeneic transplantation","volume":"19","author":"Karras","year":"2013","journal-title":"Biology Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0033","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/tid.12382","article-title":"Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients","volume":"17","author":"Ambati","year":"2015","journal-title":"Transplant Infect Dis"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0034","first-page":"633","article-title":"Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients","volume":"17","author":"King","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0035","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/infdis\/159.4.610","article-title":"Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine","volume":"159","author":"Ljungman","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0036","first-page":"427","article-title":"Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation","volume":"9","author":"Pauksen","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0037","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2141.2011.08913.x","article-title":"Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantation","volume":"156","author":"Inaba","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0038","unstructured":"Cordonnier C. Active immunization and vaccine guidelines after stem cell transplant. 2011. Available at:https:\/\/test.ebmt.org\/Contents\/Resources\/Library\/Slidebank\/Documents\/EBMT%202011%20SC%20Slide%20Bank\/100_Cordonnier.pdf. Accessed 01 June 2019"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0039","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/sj.bmt.1704678","article-title":"Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients","volume":"34","author":"Ljungman","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0040","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2217\/fvl.14.102","article-title":"An update on the management and prevention of cytomegalovirus infection following allogeneic hematopoietic stem cell transplantation","volume":"10","author":"Romero","year":"2015","journal-title":"Future Virol"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0041","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4274\/Tjh.2013.0244","article-title":"Factors associated with cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantation: human leukocyte antigens might be among the risk factors","volume":"31","author":"Acar","year":"2014","journal-title":"Turk J Haematol"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0042","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S1473-3099(11)70344-9","article-title":"A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"12","author":"Kharfan-Dabaja","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0043","first-page":"S413","article-title":"Multiple vaccination with a CMVpp65-derived peptide can prevent or clear CMVpp65 antigenemia after allogeneic stem cell transplantation","volume":"50","author":"Michael","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0044","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1111\/ajt.14925","article-title":"A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donor","volume":"18","author":"Vincenti","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0045","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.bbmt.2008.08.007","article-title":"HB vaccination in the prevention of viral reactivation in allogeneic hematopoietic stem cell transplantation recipients with previous HBV infection","volume":"14","author":"Onozawa","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0046","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2893.2006.00830.x","article-title":"Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor","volume":"14","author":"Knoll","year":"2007","journal-title":"J Viral Hepat"},{"issue":"Suppl 1","key":"10.1016\/j.bbmt.2019.10.030_bib0047","first-page":"303A","article-title":"Hepatitis B virus (HBV) reverse seroconversion after allogeneic hematopoietic stem cell transplantation (HSCT) and the impact of post\u2010transplant vaccination","volume":"58","author":"Hammond","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0048","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/01.qco.0000244050.15888.6f","article-title":"Prevention and treatment of travel-related infections in compromised hosts","volume":"19","author":"McCarthy","year":"2006","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0049","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jtm.12166","article-title":"International travel patterns and travel risks for stem cell transplant recipients","volume":"22","author":"Mikati","year":"2015","journal-title":"J Travel Med"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tmaid.2014.12.007","article-title":"Travel risk assessment, advice and vaccinations in immunocompromised travellers (HIV, solid organ transplant and haematopoeitic stem cell transplant recipients): a review","volume":"13","author":"Aung","year":"2015","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0051","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.autrev.2011.05.015","article-title":"Immunization in the adult immunocompromised host","volume":"11","author":"Lobermann","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0052","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.idc.2004.10.004","article-title":"Challenging scenarios in a travel clinic: advising the complex traveler","volume":"19","author":"Suh","year":"2005","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0053","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1016\/j.bbmt.2011.12.477","article-title":"Improving vaccination of patients pre and post bone marrow transplant","volume":"18","author":"Cooper","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0054","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/infdis\/jiv060","article-title":"Response to hepatitis A vaccination in immunocompromised travelers","volume":"212","author":"Garcia Garrido","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0055","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1586\/14760584.7.5.663","article-title":"Vaccination and immunization against travel-related diseases in immunocompromised hosts","volume":"7","author":"Kotton","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0056","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10875-015-0154-4","article-title":"Longitudinal evaluation of immune reconstitution and B-cell function after hematopoietic cell transplantation for primary immunodeficiency","volume":"35","author":"Scarselli","year":"2015","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0057","series-title":"Meningococcal Disease. CDC Yellow Book 2018: Health Information for International Travel","author":"MacNeil","year":"2017"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0058","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.bmt.1702742","article-title":"Tetravalent meningococcal polysaccharide vaccine is immunogenic in adult allogeneic BMT recipients","volume":"27","author":"Parkkali","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0059","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1086\/511859","article-title":"Zoonoses in solid-organ and hematopoietic stem cell transplant recipients","volume":"44","author":"Kotton","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0060","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.idc.2012.06.003","article-title":"The immunosuppressed traveler","volume":"26","author":"Visser","year":"2012","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0061","first-page":"647","article-title":"Yellow fever vaccine booster doses: recommendations of the Advisory Committee on Immunization Practices, 2015","volume":"64","author":"Staples","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0062","series-title":"Yellow Fever. CDC Yellow Book 2018: Health Information for International Travel","author":"Gershman","year":"2017"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0063","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1708-8305.2009.00336.x","article-title":"Successful immunization of an allogeneic bone marrow transplant recipient with live, attenuated yellow Fever vaccine","volume":"16","author":"Yax","year":"2009","journal-title":"J Travel Med"},{"issue":"Rr-1","key":"10.1016\/j.bbmt.2019.10.030_bib0064","first-page":"1","article-title":"Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Fischer","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0065","unstructured":"D'Souza A, Fretham C. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR summary slides, 2017. Available at: https:\/\/www.cibmtr.org. Accessed 01 June 2019"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0066","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.bbmt.2008.06.012","article-title":"Response to pneumococcal (PNCRM7) and Haemophilus influenzae conjugate vaccines (HIB) in pediatric and adult recipients of an allogeneic hematopoietic cell transplantation (alloHCT)","volume":"14","author":"Pao","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0067","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1016\/j.vaccine.2018.08.044","article-title":"Vaccinating donors for hematopoietic cell transplantation: a systematic review and future perspectives","volume":"36","author":"Muhsen","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0068","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/17474086.2017.1396890","article-title":"Efficacy and safety of bispecific T-cell engager blinatumomab and the potential to improve leukemia-free survival in B-cell acute lymphoblastic leukemia","volume":"10","author":"Ribera","year":"2017","journal-title":"Exp Rev Hematol"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0069","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1182\/blood-2016-04-703751","article-title":"Toxicities of chimeric antigen receptor T cells: recognition and management","volume":"127","author":"Brudno","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.10.030_bib0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/blood-2017-07-793760","article-title":"Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy","volume":"131","author":"Hill","year":"2018","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119307128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119307128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:09:44Z","timestamp":1761059384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879119307128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1083879119307128"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.10.030","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting Role of Vaccinations in Donors, Transplant Recipients, Immunocompromised Hosts, Travelers, and Household Contacts of Stem Cell Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.10.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}